Daymark Pharmaceuticals (India) Private Limited, a active private limited company, was established on 06 April 1998 in Jabalpur, Madhya Pradesh, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24232MP1998PTC012746. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.10 M and a paid-up capital of ₹1.90 M.
It upholds a compliant status. Its leadership includes Bhagwandas Batheja (Managing Director), Anjali Batheja (Whole-Time Director). It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 10, Village Sihoda, Jabalpur, Madhya Pradesh, 483053.
U24232MP1998PTC012746
012746
06 April 1998
₹2.10 M
₹1.90 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Daymark Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhagwandas Batheja | Managing Director | 06 Apr 1998 | Current |
| Anjali Batheja | Whole-Time Director | 06 Apr 1998 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daymark Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.67% increase. The company also saw a substantial improvement in profitability, with a 102.04% increase in profit. The company's net worth moved up by a moderate rise of 1.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Daymark Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2004 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Daymark Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Daymark Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daymark Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Daymark Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Daymark Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.
The activity A charge with Others of Rs. 10.00 M registered on 18 Feb 2004 with Charge ID 90209478 was modified on 15 Feb 2022. was completed.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 90209478 was registered on 18 Feb 2004. was completed.
Bhagwandas Batheja was appointed as a Managing Director was appointed as a Managing Director on 06 Apr 1998 & has been associated with this company since 27 years 7 months . was recorded as a recent event.
Progress on Anjali Batheja was appointed as a Whole-time director was appointed as a Whole-time director on 06 Apr 1998 & has been associated with this company since 27 years 7 months . was documented.
The CIN of Daymark Pharmaceuticals (India) Private Limited is U24232MP1998PTC012746.
Daymark Pharmaceuticals (India) Private Limited is headquartered at Plot No. 10, Village Sihoda, Jabalpur, Madhya Pradesh, 483053.
Daymark Pharmaceuticals (India) Private Limited was incorporated on 06 April 1998.
The current directors of Daymark Pharmaceuticals (India) Private Limited are
The primary industry of Daymark Pharmaceuticals (India) Private Limited is Manufacturing.
Daymark Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Daymark Pharmaceuticals (India) Private Limited is ₹2.10 M, and the paid-up capital is ₹1.90 M.
The compliance status of Daymark Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX